O=C(CCc1nnc(CCc2ccccc2)o1)NC[C@H]1C[C@H]2C=C[C@H]1C21CC1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?